Search

everythinglearnresearchcommunity

for

Search:↓

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Ginsenoside compound K shows promise for treating metabolic diseases like diabetes and obesity.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Ginsenoside compound K shows promise for treating metabolic diseases like obesity and diabetes, but more research is needed on its safety and effectiveness.

The mesenchymal stem cell secretome may effectively treat various diseases as an alternative to traditional stem cell therapies.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Researchers discovered potential origins and new treatments for skin cancer, including biomarkers for melanoma and therapies that reduce tumor growth.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Podcasting could improve dermatology education if it had more consistent, evidence-based content and better regulation.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

Reducing accidents and treating vascular diseases can lower the need for life-impacting amputations.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Botulinum toxin A does not significantly improve hair density or thickness in androgenetic alopecia.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

The Wnt/β-catenin pathway is important for tissue development and has potential in regenerative medicine, but requires more research for therapeutic use.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

The study concluded that AAI and DAA are forms of the same disease, with different symptoms in men and women, and that corticosteroid treatment is effective.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Hair follicle stem cells are key for hair and skin regeneration, can be reprogrammed, and have potential therapeutic uses, but also carry a risk of cancer.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Meibomian glands are highly specialized and differ significantly from other sebaceous glands in structure and function.

Hyperbaric oxygen therapy shows promise for multiple sclerosis, but skepticism and funding issues limit tech use in clinics, and outdated single-drug cancer treatments may cause unnecessary side effects.

Vitiligo treatments are improving but relapses are common.

Hair styling products can damage hair over time.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Patients should consult urologists for evidence-based erectile dysfunction treatments.